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Abstract
Paraquat (PQ) has been one of the most widely used herbicides in the world. PQ, when ingested, is 
toxic to humans and may cause acute respiratory distress syndrome. To investigate molecular 
perturbation in lung tissues caused by PQ, Sprague Dawley male rats were fed with PQ at a dose 
of 25 mg/kg body weight for 20 times in four weeks. The effects of PQ on cellular processes and 
biological pathways were investigated by analyzing proteome in the lung tissues in comparison 
with the control. Among the detected proteins, 321 and 254 proteins were over-represented and 
under-represented, respectively, in the PQ-exposed rat lung tissues in comparison with the no PQ 
control. All over- and under-represented proteins were subjected to Ingenuity Pathway Analysis to 
create 25 biological networks and 38 pathways of interacting protein clusters. Over-represented 
proteins were involved in the C-jun-amino-terminal kinase pathway, caveolae-mediated 
endocytosis signaling, cardiovascular-cancer-respiratory pathway, regulation of clathrin-mediated 
endocytosis, non-small cell lung cancer signaling, pulmonary hypertension, glutamate receptor, 
immune response and angiogenesis. Under-represented proteins occurred in the p53 signaling 
pathway, mitogen-activated protein kinase signaling pathway, cartilage development and 
angiogenesis inhibition in the PQ-treated lungs. The results suggest that PQ may generate reactive 
oxygen species, impair the MAPK/p53 signaling pathway, activate angiogenesis and depress 
apoptosis in the lungs.
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Paraquat (1,1-dimethyl-4,4′-bispyridinium dichloride) has been one of the most widely used 
herbicides in the world since its introduction to the market in 1962 [1]. It is very toxic to 
mammals including humans and ingestion may cause acute respiratory distress syndrome. 
Paraquat accumulates in the human lungs at a concentration 10 times greater than that in the 
other tissues [2]. It has been reported that PQ induces pulmonary fibrosis in humans, 
monkeys, dogs, and rats [3–9]. The major toxicity is known to cause damages in the tissues 
of lungs, livers and kidneys. It particularly makes lungs harden and causes severe lung 
injuries, such as interstitial edema, leukocyte infiltration, alveolar hemorrhage edema, 
fibroblast proliferation and collagen deposition when it is accumulated in lungs [10–12]. 
Paraquat serves as a catalyst to transfer electrons from NADPH to oxygen molecules to 
produce superoxide that breaks up cell membranes and tissues [13]. Human toxicity from 
PQ exposure takes place in two phases. The initial phase ends in death of pulmonary edema, 
cell infiltration and alveolar hemorrhage within a few days. People surviving the destructive 
phase may progress to the second proliferative phase, which lasts for several weeks [14]. 
Infiltration and proliferation of fibroblasts may cause fibrosis that eradicates alveolar tissue. 
No successful treatment has passed clinical trials although many treatment protocols for PQ 
poisoning have been studied [15–18].
PQ has been evaluated as an environmental factor that could be involved in the etiology of 
Parkinson’s disease, which is caused by a disorder affecting the dopamine neurons in the 
brain [19–21]. Involvements of dopamine and glutamate in the neural toxicity of PQ related 
to Parkinson’s disease have been proposed [6,22]. In 2011, a study funded by the U.S. 
National Institutes of Health showed a link between PQ exposure and Parkinson’s disease in 
farm workers [23].
Early diagnostic biomarkers are important for treatment of acute PQ poisoning. In order to 
investigate the characterization of diagnostic biomarkers in PQ poisoning, Kim et al. [24] 
employed a 2D-PAGE MALDI-TOF/TOF approach and identified that apolipoprotein E 
(ApoE), a precursor of haptoglobin (Hp) and fibrinogen γ-chain (FGG) were potential 
biomarkers of PQ exposure in rat sera. In an effort to develop a remedy for PQ poisoning, 
Kim et al. [25] conducted proteomic analysis of PQ-poisoned male CD(SD)IGS rat lungs to 
identify any protective effects of acai berry on the PQ poisoning.
The objectives of this study were to measure protein profiles in response to PQ and 
understand the responded protein networks in rats exposed to PQ. To our knowledge, this is 
the first comprehensive profile of soluble proteins in the lungs of rats treated with low levels 




Eight week-old Sprague Dawley Crj:CD 1GS male rats were obtained from Charles River 
Japan, Inc. (Yokohama, Kanagawa 222-0033). The rats were maintained according to the 
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protocol approved by the Korean Rural Development Administration, Korea. The rats were 
housed at a temperature of 23 ± 2°C, humidity of 55 ± 5% and luminance of 200~300 Lux 
in a constant 12 h light/12 h dark cycle. They were supplied with autoclaved water and rat 
chow (Samyang Co., Seoul, Korea). The rats were individually weighed at the beginning of 
the experiment and thereafter regularly observed for body weight, feed and water intakes for 
28 days. The lung weight and hematology were observed after a postmortem examination. 
Body weight, hematological test and clinic chemistry data were assessed by one-way 
ANOVA of the GraphPad Prism Version 5.00 (GraphPad Software, San Diego, USA).
Paraquat administration
The no observable effect level (NOEL), lowest-observed-adverse-effect level (LOAEL) and 
LD50 of paraquat dichloride (MW, 276) to Sprague Dawley male and female rats are 7 
mg/kg bw/day, 20 mg/kg bw/day and 150 mg/kg, respectively [26–28]. PQ (Sigma, St. 
Louis, MO) was dissolved in saline (100 mg/kg) and orally administered via trans-oral at 
dosages of 0 (saline control), 5, 10, 25 and 40 mg/kg bw to five groups of 10 male rats per 
group five times a week for four weeks based on a 13-week oral toxicity study [4,27]. Of the 
four treatment levels, the lungs of rats orally dosed with 25 mg/kg bw PQ, which is at 
approximately PQ LOAEL (20 mg/kg bw/day) and six times below LD50 (150 mg/kg), were 
used for profiling soluble proteins in this study.
Lung tissue samples
After animals were sacrificed, no visible symptoms of toxicity were observed in any organs 
and tissues. The lung samples were collected from the control rats and the rats dosed with 25 
mg/kg bw PQ for the proteomic studies, but not the other groups. The rats were anesthetized 
with sodium pentobarbital (50 mg/kg) via intraperitoneal (i.p.) injection prior to dissection. 
After quick removal of entire lungs, the lower half of the right lung was isolated and frozen 
in liquid nitrogen. The specimens were stored at −80°C until protein extraction. Lung 
samples from three rats of each group were randomly selected for protein extraction and 
analysis.
Protein samples
The treatment with 25 mg/kg bw PQ did not cause difference in the bw gain, hematological 
parameters and clinic chemistry. The lung sample from each rat was ground in liquid N2 
using a mortar and pestle. One hundred mg of the powdered lung tissues (wet weight) was 
extracted with 1.75 mL of a mixture of 1 mL lysis buffer and 0.75 mL protease inhibitor 
cocktail (Roche Diagnostics, Basel, Switzerland) under ultrasonication (Microson™ 
ultrasonic cell disruptor, Misonix, Farmingdale, NY) at speed level 1 for 15 min at ambient 
temperature. The lysis buffer contained 40 mM tris-HCl, pH 7.4, 5 mM dithiothreitol (DTT) 
and 1 mM phenylmethylsulfonyl fluoride. The homogenate was then centrifuged at 17,000 g 
for 30 min. The supernatant was filtered through a membrane Econofilter (0.2 mm×25 μm, 
Agilent, Palo Alto, CA) and then used for protein analysis. Protein concentrations were 
determined with Coomassie Plus™ protein assay kit (Pierce, Rockford, IL).
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One dimensional (1D) SDS-PAGE, protein digestion and peptide extraction
Lung sample solutions from the control (3.5 μL) and the 25-mg/kg bw treatment (3.9 μL) 
(both 25 μg protein equivalents) were separately mixed with SDS-PAGE sample buffer (3.5 
μL and 3.9 μL, respectively) and heated at 100°C for 5 min. The denatured proteins were 
separated on 10–20% gradient SDS-PAGE mini gels (9×10 cm, PAGE Gold Precast Gel, 
Cambrex Bioscience, Rockland, ME) followed by Coomassie dye (G-250) staining. Protein 
molecular weight (MW) was estimated with Precision plus protein standards (10 μL) (Bio-
Rad, Hercules, CA) on the gels (Supplemental data Figure 1). Each gel lane was cut into 20 
even slices, destained with 50% (v/v) acetonitrile (ACN) in 25 mM NH4HCO3, and then 
completely dried in a speed-vacuum centrifuge (vacufuge™, Eppendorf, Hamburg, 
Germany) after dehydration with ACN. The dried gel slices were reduced in 50 μL of 10 
mM DTT for 45 min at 56°C, alkylated in 50 μL of 55 mM iodoacetamide for 45 min at 
ambient temperature in the dark. The gel slice samples were dehydrated with ACN followed 
by drying in the speed-vacuum centrifuge. After addition of 20 μL of sequencing-grade 
modified porcine trypsin (20 ng/μL in 50 mM NH4HCO3), samples were incubated at 37°C 
overnight. Tryptic digestion was stopped by adding 5 μL of 2% trifluoroacetic acid (TFA). 
The digested peptides were extracted twice from each gel slice with 30 μL of 
water/ACN/TFA (93:5:2, v/v/v) by sonication for 10 min in an ice bath and then combined 
for protein analysis.
Protein identification
Digested peptides of which the proteins were separated on 1D gel were analyzed on a 
Dionex UltiMate™ 3000 LC interfaced with a Bruker esquireHCTultra ion trap mass 
spectrometer (Bruker Daltonics, Billerica, ME) in nanoelectrospray mode with a PicoTip 
Emitter (360 μm O.D., 20 μm I.D., 10 μm tip I.D., New Objective, Woburn, MA) according 
to the procedure previously described [29,30]. Mascot-peptide mass fingerprinting (PMF) 
searches and sequence alignments were performed with the Swiss-Prot databases. UniProt 
classification was used to search cellular roles of identified proteins. Peptides were assumed 
to be monoisotopic, oxidized at methionine residues and carbamidomethylated at cysteine 
residues. Up to one missed trypsin cleavage was allowed, although matches that contained 
any missed cleavages were not noticed. Peptide mass and MS/MS tolerances were set at ± 
1.0 and ± 0.8 Da, respectively. Probability-based molecular weight search (MOWSE) scores 
were estimated and were reported as: 10 × log10 (p), where p is the absolute probability. 
Scores in Mascot larger than the MOWSE score at p=0.05 were considered statistically 
significant, meaning that the probability of the match being a random event is lower than 
0.05. The false-positive rate (FPR) was estimated [31] and was smaller than 2% 
[FPR=FP/(FP+TP), where FP is the number of FPR hits; TP is the number of true-positive 
hits]. Only proteins identified with at least two peptide hits in triplicate analyses, with each 
peptide containing two tryptic termini, were accepted. In addition, the MS/MS spectra of all 
positively identified peptides were manually confirmed twice. Proteins detected in the 
treatment samples were compared with those in the saline control samples. Detection of a 
protein in the treatment sample but not in the control is referred to as over-representation, 
whereas absence of a protein in the treatment sample but presence in the control is referred 
to as under-representation. Only proteins detected in all three rat replicates were considered.
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Pathway and network analysis
Accession numbers of detected proteins (UniProt/SwissProt Ids) were listed in MS Excel 
and then imported into the Ingenuity Pathway Analysis (IPA) (Ingenuity System, Redwood 
City, CA) to create canonical pathways and networks of interacting proteins. Protein IDs 
uploaded into IPA were converted to the corresponding rat Entrez Gene symbols for display 
in pathways and networks. The data were analyzed in the context of rat (IPA ID No.: 
156502). The network scores [32–55] were based in the hyper geometric distribution and 
were calculated with the right-tailed Fisher’s Exact Test. The scores were not an indication 
of the quality or biological relevance of the network. They simply measured the approximate 
“fit” between each network and the network eligible molecules. The p values were 




All rats gradually gained body weights during the four week experiment period 
(Supplemental data Table 1). The body weights of the PQ-orally treated rats were not 
significantly different from those of control rats, although food and water consumption was 
slightly decreased in all PQ-treated rats in comparison with the control rats (data not shown). 
It is noteworthy that additional rats were also administered with PQ via i.p. or subcutaneous 
injections at the dose levels of 5, 10, 25 and 40 mg/kg bw, however, those rats gained 
significantly less weights than the PQ-orally treated rats and the saline control rats (data not 
shown).
Hematological test and clinic chemistry of rats
No significant difference was found between all PQ-treated rat groups and the control group 
for the hematological parameters (Supplemental data Table 2) and for the clinic chemistry 
(Supplemental data Table 3).
Differentially expressed proteins
A total of 1033 and 1120 proteins was detected in the lungs of the control rats and PQ-
exposed rats, respectively, while 756 of these proteins were detected in both groups (Figure 
1, I, Supplemental data Table 4 and Table 5). There were 254 and 321 proteins under- and 
over-represented, respectively, in the lungs of rats treated with PQ at 25 mg/kg bw as 
compared with the control rats. Among the 254 under-represented proteins, 65 proteins that 
had 8 or more matched peptides per protein, Mascot scores higher than 140 and known 
biological functions were considered as major under-represented proteins (Table 1). Among 
the 321 over-represented proteins, 57 proteins that had 12 or more matched peptides per 
protein, Mascot scores higher than 134 and known biological functions were considered as 
major over-represented proteins (Table 2).
Under-represented proteins—Table 1 shows that major under-represented proteins 
involved in p53 signaling and MAPK signaling pathways, apoptosis, angiogenesis inhibition 
and B cell receptor complex. The major under-represented proteins involved in p53 
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signaling pathway include TP53BP1, BCL11B, DPH1, HIC1 and CHTF8 in the lungs of rats 
treated with 25 mg/kg bw of PQ. However, these proteins were detected in the lung tissues 
of the control rats.
Over-represented proteins—The over-represented proteins include DUSP10, 
MAPK8IP2, CASR and MAP3K1 (Table 2). These proteins are related to the c-Jun N-
terminal kinase (JNK) pathway, which is also known as stress-activated protein kinase 
(SAPK) [32–34]. It plays a role on responses to diverse environmental stresses [35–37]. 
Over-represented proteins associated with immune response and antioxidant defense 
included MARCO, NLRX1, FAIM3, C1orf38, Cd55/Daf2, BCL3, TXNRD3 and RNF125 in 
the lungs of rats treated with PQ. Macrophages are regulators of homeostasis and effecter 
cells in infection wounding and tumor growth in the immune system [38].
The findings indicated pulmonary stresses and activation of antioxidant defense system and 
immune system responses in rat lungs against adverse effects after PQ exposure [10,39,40]. 
Angiogenesis-related proteins such as roundabout homolog 4, ETS domain-containing 
protein Elk-3, collagen alpha-2 (IV) chain and nitric oxide synthase were over-represented 
in the lung tissues from rats treated with PQ. In addition, glutamate receptor (ionotropic, 
metabotropic 5, metabotropic 1) proteins were over-represented in the rat lungs.
Protein networks
Out of the 254, 321 and 756 of under-represented, over-represented and overlapped proteins, 
226, 305 and 711 identifies (IDs), respectively, were mapped into 25 biological networks 
and 72 pathways of interacting protein clusters according to the identifiers’ HomoloGene to 
the ortholog information in the Ingenuity Knowledge Base (IKB) (Rat data) (Figure 1, II). 
The IKB contains published findings for both genes and proteins. However, for display 
purposes, only gene names were used, even when proteins IDs were uploaded. The 
biological network of differentially expressed proteins showed inter-relationships and 
relevant signaling pathways (Figure 2). One overall network was merged from the 5 highest 
scored (scores, 30–53) networks (A, cell-to-cell signaling and interaction; B, cell signaling; 
C, cell cycle: D, genetic disorder: E, cellular movement). In the network, interrelationships 
of proteins linked to central hubs (11 small circles in Figure 2) present cellular assembly and 
organization, cellular function and maintenance, developmental disorder. The network 
showed that a fibrosis is correlated with the expression of an alpha-1 collagen (Figure 2) in 
the PQ-treated rat lungs.
Table 3 presents top five up- and down-regulated network functions, canonical pathways, 
toxicity (tox) lists and functions in rat lung tissues in response to PQ exposure. Twenty five 
networks and 42 pathways were up-regulated in the lungs of PQ-treated rats, whereas 25 
networks and 54 pathways were down-regulated. The top up-regulated canonical pathways 
in which many over-represented proteins were detected were protein kinase A signaling 
(Figure 3), caveolae-mediated endocytosis signaling (Supplemental data Figure 2), EGF 
signaling, GNRH signaling and cardiac β-adrenergic signaling (Table 3). The top down-
regulated canonical pathways in which under-represented proteins were detected were 
putative molecular mechanisms of cancer (Supplemental data Figure 3), acute myeloid 
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leukemia signaling, erythropoietin signaling, mechanisms of viral exit from host cells and 
IL-3 signaling (Table 3). The top tox lists were increase of adenylate cyclase, hepatic 
fibrosis, renal necrosis/cell death, TR/RXR activation and PXR/RXR activation (Table 3). 
The top down-regulated tox lists included VDR/RXR activation, G2/M DNA damage 
checkpoint regulation, cardiac fibrosis, PPARα/RXRα activation and p53 signaling (Table 
3). Top up-regulated functions in the lungs of PQ-treated rats were 1) cardiovascular-cancer-
respiratory, which is related to respiratory-nitric oxide synthase (NOS3), 2) clathrin-
mediated endocytosis, which is regulated by AP2-associated protein kinase (AAK1), 3) 
immune response/oxidative stress/pulmonary hypertension, 4) non-small cell lung cancer, 
which comprises about 80% of all lung cancers, 5) neurotransmitter/collagen synthesis 
(Table 3). Top down-regulated functions were 1) epithelial cell differentiation signaling, 2) 
cartilage/cerellum/lung development, 3) mitogen-activated protein kinases signaling, 4) 
transforming growth factor β (TGF-β) signaling, and 5) tumor suppressor. The results of the 
present study supported the previous studies of which PQ might induce pulmonary fibrosis, 
e.g., up-regulation of neurotransmitter, collagen synthesis and oxidative stress and down-
regulation of epithelial cell differentiation, lung development and TGF-β signaling, cellular 
reactive oxygen species (ROS) in the PQ-treated rat lungs [4,6,8,9,11,41].
Up-regulation of protein kinase A signaling in the lungs of PQ-treated rats
Protein Kinase A (PKA) signaling was found to be the highest dominant canonical pathway 
(Figure 3). PKA regulates processes as diverse as growth, development, memory and 
metabolism [40]. It exists as a tetramer complex of two catalytic subunits (PKA-C) and a 
regulatory (PKA-R) subunit dimmer. Twenty six proteins were associated with the PKA 
signaling. Up-regulated proteins in the PQ-treated rat lungs included histone cluster 
(HIST1H1A), adenylate cyclase (ADCY9), kinase anchor protein 6, 11 and 12 (AKAP6, 
AKAP11 and AKAP12, respectively), flamin A (FLNA), paxllin (PXN), inositol 1,4,5-
triphosphate receptor (ITPR1), ITPR3, mitogen-activated protein kinase kinase kinase1 
(MAP3K1), nitric oxide synthase (NOS3), phosphodiesterase 10A (PDE10A), PDE 3A, 
PDE 3B, PDE4B, and PDE4D. Down-regulated proteins in the PQ-treated rat lungs included 
anaphase promoting complex subunit 1 (ANAPC1), flaming B (FLNB), v-raf-1 murine 
leukemia viral oncogene homolog 1 (RAF1), transcription factor 4 (TCF4), transcription 
factor 7 like 2 (TCFTL2), protein kinase C. zeta (PRKCZ), protein kinase C. alpha 
(PRKCA), phosphodiesterase 12 (PDE12), inositol 1,4,5-triphosphate receptor 2 (ITPR2), β-
catenin-T-cell factor and lymphoid enhancer factor complexes (TCF/LEF). In particular, the 
TCF/LEF complexes that are related to Wnt signaling pathway were down-regulated, while 
p53 binding protein 1 (TP53BP1) was not detected in the PQ-treated rat lungs.
These findings indicated that up-regulation of the canonical Wnt signaling pathway may 
induce cancer formation since p53-mediated Wnt repression has not taken place in the lungs 
and then loss of p53 function may contribute to cancer formation [41].
P53 signaling pathway in rat lungs relevant to PQ exposure
The p53 tumor suppressor protects against cancer by eliminating cells that have suffered 
DNA damage or proliferate in an uncontrolled manner [44]. Loss of p53 function is thought 
to be a contributing factor in the majority of cancer cases [43]. The p53 tumor suppressor 
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protein regulates the expression of a wide variety of genes involved in apoptosis, growth 
arrest, inhibition of cell cycle progression, differentiation and accelerated DNA repair or 
senescence in response to genotoxic or cellular stress (Figure 4) [45]. In the p53 signaling 
pathway, phosphate and tensin (PTEN), p53, Bcl-2, PARP apoptosis inhibitors, ABT-263, 
ABT-737, AZD 2281 and YM155 are apoptosis inhibitors [44,46]. Bcl-2 regulates 
apoptosis, which is a cell suicide program that normally responds to stresses such as growth 
factor deprivation, cytokine exposure, DNA damage, cell cycle dysfunction and oncogene 
activation [47–49]. We have found that tumor suppressor p53-binding protein 1, B-cell 
lymphoma/leukemia 11B, diphthamide biosynthesis protein 1, hypermethylated in cancer 1 
protein, and chromosome transmission fidelity protein 8 homolog isoform 2 were down-
represented in the PQ treated groups compared with the control group. These proteins are 
related to p53 signaling pathway that suppresses development of tumor in lungs. The results 
indicated that p53 signaling pathway was down-regulated through activation of Wnt 
signaling pathway where proteins were over-represented, which included adenomatous 
polyposis coli protein 2 (APC2), tuber in/tuberous sclerosis 2 (TSC2), leucine-rich repeat 
flightless-interacting protein 2 (LRRFIP2), dapper homolog 1 (DACT1), GSK-3-binding 
protein (FRAT2) and microtubule-actin cross-linking factor 1 (MACF1) in the PQ-treated 
rat lungs. The proteins involved in the p53 signaling pathway, MAPK signaling pathway, 
cartilage development and angiogenesis inhibition were under-represented in the lungs of 
the PQ-treated rats.
The findings indicated that PQ affected the p53 signaling pathway (Figure 4) and, thus, the 
impaired p53 pathway might lead to the activation of angiogenesis in lungs. PQ might cause 
inhibition of p53 signaling pathway, which tumor suppressor p53 binding protein 1 and B-
cell lymphoma/leukemia 11B were not detected in the PQ-treated rat lungs, but detected in 
the control rat lungs (Table 1).
Discussion
PQ NOEL for Sprague Dawley male and female rats was 7 mg/kg bw/day [26]. The median 
lethal dose of PQ for male rats was approximately 344 mg/kg bw [26,50]. In the present 
study, the exposure levels (5–40 mg/kg bw) resulted in no significant difference of bw gain, 
hematological parameters and clinic chemistry between the PQ-treated groups and the 
control. We hypothesized that low levels of PQ that do not cause phenotypic changes would 
cause differences in protein profiles and networks.
Protein profile changes in the PQ-treated rat lungs were evaluated through IPA in 
comparison with those in the PQ-free rat lungs. Caveolae-mediated endocytosis signaling 
that plays a role in various cellular processes such as endocytosis, cellular signaling and 
lipid recycling was up-regulated in the PQ-exposed rat lungs (Supplemental data Figure 2). 
Coatomer subunit gamma-2 (COPG2), EGF, EGFR, filamin A alpha (FLNA), complement 
decay-accelerating factor transmembrane isoform (Cd55/Daf2), integrin α 1 (ITGA1), 
ITGA2B, integrin α-X (ITGAX) and intersection-1/SH3 domain protein (ITSN1) are 
associated with caveolae-mediated endocytosis signaling. Internalization of caveolae can be 
induced by numerous stimuli, including insulin, EGF, hyperosmotic and oxidative stress, 
cholera toxin, bacteria and viruses. Upon cell detachment from the extracellular matrix 
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(ECM), phosphorylated caveolon-1 translocates from focal adhesions to caveolae, where it 
induces its internalization. Putative molecular mechanisms of cancer were down-regulation 
of 11 proteins in the PQ-treated rat lungs (Supplemental data Figure 3). The associated 
proteins include RAC-β serine/threonine protein kinase (AKT), Rho guanine nucleotide 
exchange factor (ARHGEF), Janus kinase (JAK), low density lipoprotein receptor-related 
protein 6 (LRP6), protein kinase C α (PRKCA), protein kinase zeta (PRKCZ), V-raf-1 
murine leukemia viral oncogene homolog 1 (RAF1), synaptic Ras GTPase activating protein 
1 (SYNGAP1), mitogen-activated protein kinase kinase kinase 7-interacting protein 
(TAB2), transcription factor 4 (TCF4) and protein kinase DNA-activate, and catalytic 
polypeptide (PRKDC). Major signaling pathways involved in inter- and intracellular 
communication leading to malignant phenotypes include GPCR signaling, Ras/integrin 
signaling, Akt signaling, TGF-β/BMP signaling, Wnt signaling, Notch and Hedgehog (Hh) 
signaling, and death receptor signaling.
The EGF signaling is the strongest functional association identified for this set of 18 
identifiers (p=1×10−3, Fischer’s exact test). The 18 proteins that were detected in the PQ-
free rat lungs, but not in the PQ-treated rat lungs (Table 1) were grouped to 11 canonical 
biological process pathways. Platelet-derived growth factor (PDGF) signaling, NF-kB 
activation by viruses, ceramide signaling, regulation of IL-2 (Interleukin 2) expression in 
activated and anergic T lymphocytes, phosphatase and tensin homolog (PTEN) signaling as 
well as the EGF signaling were found to be the dominant canonical pathways. One overall 
network was merged from the 2 highest scored (19, 13) networks (cell signaling; cell death) 
(Figure 5). Cardiovascular system development and function was the highest network 
identified for 18 identifiers. In the overall network, cysteine/serine-rich nuclear protein 3 
(CSRNP3) and potassium voltage-gated channel subfamily H member 8 (KCNH8) among 
18 identifies have not been eligible. Endomucin (EMCN) and POU domain class 3 
(POU3F3) among 18 identifies have not been found to be involved in the scored (19 and 13) 
networks of cell signaling and cell death since the EMCN and POU3F3 belong to the cell-
mediated immune response network (score, 3) and cellular growth (score, 2), respectively. 
Network score was based on the hyper geometric distribution and was calculated with the 
right-tailed Fisher’s Exact Test. The score was not an indication of the quality or biological 
relevance of the network; it simply measured the approximate “fit” between each network 
and network eligible molecules. The p-value is associated with a function or a pathway in 
GFA and GCP. The smaller is the p-value, the less likely random and the more significant is 
the association. In general, p-values less than 0.05 indicate a statistically significant, non-
random association. The p-value was calculated using the right-tailed Fisher Exact Test. The 
pathway was activated with MAP3K1 and RAF1. These two proteins are involved in the 
EGF, PDGF, T cell receptor, Rac renin-angiotensin, SAPK/JNK, NF-kappa-B, ceramide 
signaling, and regulation of IL-2 expression in activated and anergic T lymphocytes (Figure 
5).
Damage of p53-mediated apoptosis discloses a wide network of signaling pathway that is 
activated by p53 to make sure an appropriate response to a cellular stress [51]. p53 is known 
as a tumor suppressor protein encoded by the TP53 gene in humans. Some of the under-
represented proteins in the network (Figure 5) were involved in the p53-signaling pathway 
(TP53BP1, BCL11B, DPH1 and HIC1), apoptosis (CSRNP3, PCNT and TRIM35), negative 
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regulation of apoptosis (POU3F3 and KCNH8) and angiogenesis inhibition (BAI2 and 
EMCN). The suppression of tumorigenicity protein 18 (ST18) is related to the repression of 
basal tram inscription activity from target promoters [52]. The breast cancer anti-estrogen 
resistance protein 1 (BCAR1) is involved in B cell receptor signaling pathway [53].
Synaptic long term depression was the strongest functional association identified for this set 
of 28 identifiers (p=1×10−5, Fischer’s exact test). The 26 identifiers that were detected in the 
PQ-treated rat lungs, but not in the PQ-free rat lungs (Table 2) were grouped to 14 canonical 
biological pathways. The dominant canonical pathways were the synaptic long term 
depression, glutamate receptor signaling, SAPK/c-Jun N-terminal kinase (JNK) signaling, 
neuropathic pain signaling in dorsal horn neurons, synaptic long term potentiating. One 
overall network was merged from the 2 highest scored (38, 25) networks (cell-to-cell 
signaling and interaction; cell cycle, cell-to-cell signaling and interaction) (Figure 6). Cell 
cycle was the highest network that was created with 26 identifiers. Among the 26 identifiers, 
protein THEMIS2 (C1orf38) has not been involved in the scored (38 and 25) networks since 
the Clorf38 belongs to the cellular development (score, 2). The pathway was activated with 
glutamate receptors (GRIA1, GRM1 and GRM5) and nitric oxide synthase 3 (NOS3) 
(Figure 6), which these proteins are involved in glutamate receptor signaling, neuropathic 
pain signaling in dorsal horn neurons and CREB signaling in neurons [52]. Huang et al. [55] 
reported that the activation of rat p38 MAPK protein increased the long term depression of 
synapse, which is dependent on rat GRM5 protein that was over-presented (Figure 6). Some 
of the expressed proteins in the network (Figure 6) were involved in the JNK pathway 
(DUSP10, MAPK8IP2, MAP3K1 and CASR), innate immune response (MARCO, NLRX1, 
FAIM3, Cd55/Daf2, BCL3 and RNF125), the macrophage inflammatory response (C1orf38) 
and angiogenesis (ROBO4, ELK3, COL4A2 and NOS3). The finding indicates that PQ 
induces oxidative stress, activation of antioxidant defense system and immune responses, 
and then leads to apoptotic death of neuronal cells in PQ-exposed lungs. The B-cell 
lymphoma 3-encoded protein homolog (BCL3) is related to T-helper 1 type immune 
response in nucleus as a transcriptional activator that promotes transcription of nuclear 
factor kappa-light-chain-enhancer of activated B cells (NF-kB) target genes. The NF-kB, 
controlling the transcription of DNA, is involved in cellular responses to stimuli and plays a 
key role in regulating the immune response to infection [56]. AP2-associated protein kinase 
1 (AAK1) and NOS3 were related to the clathrin-mediated endocytosis and cardiovascular-
cancer-respiratory pathway, respectively. In particular, the NOS3 pathway induces 
pulmonary hypertension, oxidation stress of heart. Regulation of clathrin-mediated 
endocytosis by AAK1 presents cell death of epithelia cell lines, cell death of kidney cell 
lines and cell death of embryonic cell lines [57]. CDKN2A-interacting protein (CDKN2AIP) 
is associated with the activation of TP53/p53 that can be induced by CDKN2Adependent 
and CDKN2A-independent pathways.
The findings indicated up-regulation of the neurotransmitters, JNK pathway, immune 
response, and angiogenesis, but down-regulation of MAPK signaling pathway, p53 signaling 
pathway and angiogenesis inhibition in the PQ-exposed rat lung tissues. PQ may generate 
ROS and impair the MAPK/p53 signaling pathway and, thus, may lead to the activation of 
angiogenesis and fibrosis in the lungs [58]. Tung et al. [59] reported that PQ increased 
connective tissue growth factor (CTGF) and collagen expression by activating the 
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angiotensin signaling pathway in human lung fibroblasts. In the present study, proteins 
involved in the angiotensin signaling, connective tissue disorder and collagen were over-
induced in the PQ-exposed rat lungs relative to the corresponding proteins in the PQ-free 
control rat lungs. The angiotensin II probably formed from angiotensin I, which has no 
biological activity as a precursor to angiotensin II, through removal of two C-terminal 
residues by the angiotensin-converting enzyme (ACE) that was conserved in the two lung 
groups (Supplemental data Table 6). ACE is found predominantly in the capillaries of lungs. 
The angiotensin II, a peptide hormone, has a role to cause blood vessels to constrict and 
drives blood pressure up [59]. It indicated that PQ probably inhibits production of ubiquinol. 
These results agreed with the report of Bus et al. [10], which PQ (30 mg/g) significantly 
decreased lipid-soluble antioxidant concentrations in lungs. Tomita et al. [2] reported that 
antioxidant defense system enzymes were up-regulated against oxidative stress in the mouse 
lungs and the lipid-soluble antioxidant regulated NAD(P)H dehydrogenase, quinone 1 
(gene) was up-regulated. However, our work presented that NADH dehydrogenase 
(ubiquinone) iron-sulfur protein 8, which is related to electron transport, was found to be 
down-regulated in the treatment sample (Supplemental data Table 4). It is noteworthy that 
Kim et al. [24] reported great induction of ApoE, Pphg, Hp and C3 proteins and dramatic 
reduction of FGG and Ac-158 in sera upon PQ exposure, which, however, were not detected 
in the lung tissues in the present study (Supplementary data Table 5).
Conclusion
There were no overt signs of toxicity based on lack of change in body weight, clinical 
chemistry, and hematological parameters at a dose of about 7% of the acute LD50. However, 
the expression profile of soluble proteins in the lung shows significant alterations in 
hundreds of proteins in the PQ-exposed (25 mg/kg) rat lung tissues in comparison with the 
PQ-free control rat lungs. The profile indicates that PQ induces oxidative stress and then 
leads to apoptotic death of neuronal cells. Eventually, activation of antioxidant defense 
system and immune responses in lungs after PQ exposure signify potential induction of 
pulmonary stresses and diseases. PQ may generate ROS and impair the MAPK/p53 
signaling pathway and, thus, may lead to the activation of angiogenesis and fibrosis in the 
lungs.
The results of the present study were interpreted with particular emphasis on the p53 
signaling pathway, which suggests PQ effects on apoptosis and angiogenesis, tumor 
suppression, cell cycle progression, cell cycle arrest, cell survival, autophagy, mitochondrial 
respiration, DNA repair, senescence and glycolysis in lungs.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Venn diagrams showing 1033 and 1120 proteins detected (I), 937 and 1016 proteins mapped 
(II) in the lungs of the control and PQ-treated rats, respectively. The number of proteins 
detected was indicated in the parentheses.
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Five sub-networks were highlighted with thick circles. Eleven small circles identified 
proteins that also served as hubs for groups of proteins. Proteins in red were the over-
represented, while proteins in green were under-represented. Solid grey lines and dotted 
grey lines indicated direct and indirect interactions, respectively. Arrow-headed lines and 
simple lines without arrows indicated ‘acts on’ and ‘binding only’, respectively. Solid 
orange lines and dotted orange lines indicated highlighted direct and indirect interactions, 
respectively. Lines connecting the proteins indicated known interrelationships from the IPA 
database.
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Up-regulation of protein kinase A signaling in the lungs of PQ-treated rats. Proteins in red 
were the over-represented, while proteins in green were the under-represented. Proteins in 
half green and half red were detected in both the PQ-free and PQ-treated rat lungs. Proteins 
in white and grey indicated that the proteins are related to the signaling, but were not 
detected. In addition, proteins in grey were hubs
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Proposed p53 signaling pathway in PQ-treated rat lungs.
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Canonical pathway and gene network analysis of the 18 identifiers that were expressed in 
the lungs of PQ-free rats. The 18 identifiers were analyzed using IPA and the identifiers 
were grouped to 11 canonical biological process pathways. The EGF signaling, PDGF 
signaling, NF-kB activation by viruses, ceramide signaling, regulation of IL-2 expression in 
activated and anergic T lymphocytes, and PTEN signaling were found to be the dominant 
canonical pathways represented by the identifiers. p-Value <0.05 indicated that a maximum 
False Discovery Rate of 5% was accepted in the functional analysis of IPA. A representative 
protein network of the dominant canonical pathways was then generated. The networks was 
obtained by merging the 2 highest scored networks into one overall network; cell signaling, 
cardiovascular system development (score 19), cell death (score 13). CSRNP3 and KCNH8 
were not eligible to mapping. POU3F3 and EMCN were not involved in the highest scored 
networks. Solid grey lines and dotted grey lines indicated direct and indirect interactions, 
respectively. Arrow-headed lines and simple lines without arrows indicated ‘acts on’ and 
‘binding only’, respectively. Solid orange lines and dotted orange lines indicated highlighted 
direct and indirect interactions, respectively.
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Canonical pathway and gene network analysis of the 26 identifiers that were expressed in 
the lungs of PQ-treated rats. The 26 identifiers were analyzed using IPA and the identifiers 
were grouped to 14 canonical biological process pathways. The synaptic long term 
depression, glutamate receptor signaling, SAPK/JNK signaling, neuropathic pain signaling 
in dorsal horn neurons and synaptic long term potentiation were found to be the dominant 
canonical pathways represented by the identifiers. A representative protein network of the 
dominant canonical pathways was then generated. The network was obtained by merging the 
2 highest scored networks into one overall network; cell-to-signaling and interaction, 
nervous system development and function, cell cycle. C1orf38 was not involved in the 
highest scored network. Solid grey lines and dotted grey lines indicated direct and indirect 
interactions, respectively. Arrow-headed lines and simple lines without arrows indicated 
‘acts on’ and ‘binding only’, respectively. Solid orange lines and dotted orange lines 
indicated highlighted direct and indirect interactions, respectively.
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Table 1
Major under-represented proteins in lungs of rats that were orally administered with PQ at 25 mg/kg bw for 
five times a week for four weeks.
Protein name (gene symbol*) A† B† C† Biological function
p53 signaling pathway
Tumor suppressor p53-binding protein 1 (TP53BP1) 14 160 (29) P70399 Checkpoint signal during mitosis
B-cell lymphoma/leukemia 11B (BCL11B) 18 194 (29) Q99PV8 Tumor-suppressor protein involved in T-cell 
lymphomas, BCL-11B (Radiation-induced tumor 
suppressor gene 1 protein)
Diphthamide biosynthesis protein 1 (DPH1) 14 142 (29) Q5NCQ5 Tumor suppressor in lung and breast cancers
Hypermethylated in cancer 1 protein (HIC1) 15 160 (29) Q9R1Y5 Tumor suppressor (Development of head, face, 
limbs and ventral body wall)
Chromosome transmission fidelity protein 8 homolog 
( CHTF8)
18 158 (29) B2RYL1 Potential tumor suppressor
MAPK signaling pathway or related proteins
Mitogen-activated protein kinase kinase kinase 1 
(MAP3K1)
14 136 (30) Q62925 Activation of JNKK activity up
Neurofibromin 1 ( NF1) 14 165 (30) P97526 MAPKKK cascade
RAF proto-oncogene serine/threonine-protein kinase 
(RAF1)
13 145 (30) P11345 MAPKKK cascade
Suppression of tumorigenicity protein 18 (ST18) 13 145 (30) Q9QX27 Negative regulation of transcription from RNA 
polymerase II promoter
Apoptosis
Cysteine/serine-rich nuclear protein 3 (CSRNP3) 12 141 (30) P59055 Apoptosis
Pericentrin (PCNT) 12 144 (30) P48725 Apoptosis
Tripartite motif-containing protein 35 (TRIM35) 12 134 (30) Q5RKG6 Apoptosis
POU domain, class 3 (POU3F3) 13 150 (30) Q63262 Negative regulation of apoptosis
Potassium voltage-gated channel subfamily H member 
8 (KCNH8)
12 141 (30) Q9QWS8 Negative regulation of apoptosis
Angiogenesis inhibition
Brain-specific angiogenesis inhibitor 2 (BAI2) 14 166 (30) Q8CGM1 Angiogenesis inhibition
Endomucin (EMCN) 12 137 (30) Q6AY82 Angiogenesis
B cell receptor
Breast cancer anti-estrogen resistance protein 1 
(BCAR1)
13 139 (30) Q63767 B cell receptor signaling pathway
DNA-dependent protein kinase catalytic subunit 
(PRKDC)
15 150 (29) P97313 B cell lineage commitment (serine/threonine-protein 
kinase)
*
Protein IDs uploaded into IPA were converted to the corresponding Entrez Gene symbols for display in Pathways and Networks. Ingenuity’s 
knowledge base contained published findings for both genes and proteins. However, for display purposes, only gene names were used (even when 
protein IDs were uploaded)
†
A: Number of matched peptides; B: Mascot score (p = 0.05); C: Protein accession number.













Cho et al. Page 22
Table 2
Major over-represented proteins in lungs of rats that were orally administered with PQ at 25 mg/kg bw for five 
times a week for four weeks.
Protein (gene symbol*) A† B† C† Biological function
c-Jun N-terminal kinase (JNK) pathway
Dual specificity protein phosphatase 10 
(DUSP10)
15 143 (30) Q9ESS0 Negative regulation of JNK cascade
C-jun-amino-terminal kinase-interacting 
protein 2 (MAPK8IP2)
18 296 (30) Q9ERE9 The JNK-interacting protein (JIP)
Extracellular calcium-sensing receptor 
(CASR)
13 145 (30) P48442 JNK cascade
Mitogen-activated protein kinase kinase 
kinase 1 (MAP3K1)
14 136 (30) Q62925 Activation of JNKK activity
Immune response
Macrophage receptor (MARCO) 14 255 (33) Q60754 Innate immune response
NLR family member X1 (NLRX1) 13 251 (33) Q5FVQ8 Innate immune response
Fas apoptotic inhibitory molecule 3 (FAIM3) 12 146 (32) Q5M871 Immunity
Protein THEMIS2 (C1orf38) 15 141 (30) Q91YX0 Macrophage inflammatory response
Complement decay-accelerating factor 
transmembrane isoform (Cd55/Daf2)
19 141 (33) Q61476 Complement pathway/Innate Immunity
B-cell lymphoma 3-encoded protein 
homolog (BCL3)
15 258 (30) Q9Z2F6 T-helper 1 type immune response
Thioredoxin reductase 3 (TXNRD3) 17 384 (30) Q99MD6 Glutaredoxin
E3 ubiquitin-protein ligase RNF125 
(RNF125)




14 143 (30) Q9JM53 Apoptosis
Phosphofurin acidic cluster sorting protein 2 
(PACS2)
12 251 (32) Q3V3Q7 Apoptosis
Dual specificity tyrosine-phosphorylation-
regulated kinase 2 DYRK2)
11 258 (30) Q5U4C9 Apoptosis
Homeodomain-interacting protein kinase 2 
(HIPK2)
12 145 (30) Q9QZR5 Apoptosis
Angiogenesis
Roundabout homolog 4 (ROBO4) 13 249 (33) Q80W87 Angiogenesis
ETS domain-containing protein (ELK3) 14 145 (33) P41971 Angiogenesis
Collagen alpha-2 (IV) chain (COL4A2) 12 140 (30) P08122 Angiogenesis
Nitric oxide synthase 3 (NOS3) 12 140 (30) P70313 Lung development/Cardiovascular-cancer-respiratory pathway
Neurotransmitters
Glutamate receptor, metabotropic 5 (GRM5) 13 252 (30) P31424 Neurotransmitters
Glutamate receptor, metabotropic 1 (GRM1) 16 143 (29) P97772 Neurotransmitters
Glutamate receptor, ionotropic (GRIA1) 12 141 (33) P19490 Neurotransmitters
Activation of TP53/p53
CDKN2A-interacting protein (CDKN2AIP) 8 185 (32) Q8BI72 Activation of TP53/p53
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Protein (gene symbol*) A† B† C† Biological function
Chromatin modification
BCL-6 corepressor (BCOR) 13 253 (32) Q8CGN4 Negative regulation of gene-specific transcription from RNA 
polymerase II promoter
Clathrin-mediated endocytosis
AP2-associated protein kinase 1 (AAK1) 17 274 (32) P0C1X8 Clathrin-mediated endocytosis
*
the same as Table 1 footnote.
†
A: Number of matched peptides; B: Mascot score (p=0.05); C: Protein accession number.
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Table 3
Network functions, top canonical pathways, tox lists and top molecules in rat lung tissues in response to 
paraquat.
Up-regulation Down-regulation
A. Top five up- and down-regulated network functions (network scores*)
1. Cell signaling, cell death, post-translational modification (35) 1. Genetic disorder, neurological disease, cell-to-cell signaling 
and interaction (43)
2. Cell cycle, cellular assembly and organization, cancer (35) 2. Organism injury and abnormalities, reproductive system 
disease, skeletal and muscular system (41)
3. Developmental disorder, neurological disease, cardiovascular system 
development and function (34)
3. Endocrine system disorder, genetic disorder, metabolic 
disease (32)
4. Cell signaling, DNA replication, recombination, and repair, nucleic acid 
metabolism (30)
4. Cell-to cell signaling and interaction, tissue development, 
cellular movement (29)
5. Connectible tissue disorder, genetic disorder, dermatological diseases and 
conditions (26)
5. Dermatological diseases and conditions, genetic disorder, 
cancer (21)
B. Top five up- and down-regulated canonical pathways (p values†)
1. Caveolae-mediated endocytosis signaling (2.83E-07) 1. Molecular mechanisms of cancer (1.93E-04)
2. Protein kinase A signaling (1.02E-05) 2. Acute myeloid leukemia signaling (2.95E-04)
3. EGF signaling (8.92E-05) 3. Erythropoietin signaling (1.16E-03)
4. GNRH signaling (1.67E-04) 4. Mechanisms of viral exit from host cells (1.23E-03)
5. Cardiac β-adrenergic signaling (2.69E-04) 5. IL-3 signaling (1.5E-03)
C. Top five up- and down-regulated tox lists (p values†)
1. Increase glomercular injury (1.06E-02) 1. VDR/RXR activation (1.36E-02)
2. Hepatic fibrosis (1.2E-02) 2. G2/M DNA damage checkpoint regulation (1.9E-02)
3. Renal necrosis/cell death (3.11E-02) 3. Cardiac fibrosis (2.6E-02)
4. TR/RXR activation (4.99E-02) 4. PPARα/RXRα activation (5.11E-02)
5. RXR/RXR activation (9.64E-02) 5. p53 signaling pathway (1.88E-02)
D. Top five up- and down-regulated canonical functions
1. Cardiovascular-cancer-respiratory 1. Epithelial cell differentiation signaling
2. Clathrin-mediated endocytosis 2. Cartilage and Cerellum and Lung development
3. Immune response and Oxidative stress and Pulmonary hypertension 3. Mitogen-activated protein kinases signaling
4. Non-small cell lung cancer 4. Transforming growth factor β (TGF-β)signaling
5. Neurotransmitter and collagen synthesis 5. Tumor suppressor and Angiogenesis inhibition
*
network scores given in the parentheses were based in the hyper geometric distribution and were calculated with the right-tailed Fisher’s Exact 
Test. The scores were not an indication of the quality or biological relevance of the network; they simply measured the approximate “fit” between 
each network and the network eligible molecules.
†
p values in the parentheses were associated with a function or a pathway in Global Functional Analysis (GFA) and Global Canonical Pathway 
(GCP); a measure of the likelihood that the association between a set of focus genes in the experiment and a given process or pathway was due to a 
random chance.
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